Aspen Pharmacare Holdings Profit Margin

The latest profit margin for APNHY is 1.91% as of December 2025. That compares with 10.61% in the prior-year period — down 82.0% year over year. That is below the Healthcare sector average of 14.34%. Investors often review this figure alongside Aspen Pharmacare Holdings's historical trend and sector peers before judging valuation or financial health.

Over the past year, APNHY's profit margin moved from 10.61% to 1.91% — a 82.0% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Aspen Pharmacare Holdings's valuation or profitability profile.

Against Healthcare companies, APNHY currently prints 1.91% for profit margin, while the sector average sits near 14.34%. That is roughly 86.7% below the sector mean. Large gaps often invite a closer look at Aspen Pharmacare Holdings's growth, margins, and balance sheet.

Profit Margin shows how effectively Aspen Pharmacare Holdings converts resources into returns. At 1.91%, APNHY may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with 10.61% in the prior-year period — down 82.0% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting APNHY's profit margin (1.91%), review year-over-year change from 10.61%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.